HIGHLIGHTS
- who: Rebekka Mispelbaum from the Laval University, Canada have published the research work: Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors, in the Journal: (JOURNAL)
- what: The aim of this study was to approach the question whether RBC transfusions impact outcome of IT in cancer patients. All variables included in this analysis had u22645% missing. The authors demonstrate that the concomitant administration of RBC concentrates negatively influences the response rate to IT.
- how: The authors conducted a retrolective clinical study of patients treated with IT for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.